OncoveryCare is a technology company.
OncoveryCare has raised $5.0M across 1 funding round.
OncoveryCare has raised $5.0M in total across 1 funding round.
OncoveryCare is a healthtech startup building the first virtual survivorship clinic, delivering comprehensive, whole-person care—including physical, mental, social support, survivorship care planning, navigation to resources, and education—to cancer survivors.[1][2][3] Founded in 2022 by breast cancer survivor Hil Moss (CEO) and clinician Dr. Justin Grischkan (Chief Medical Officer), it addresses the growing needs of cancer survivors amid medical advances that boost survival rates, serving survivors, health plans, and health systems through personalized, longitudinal virtual programs like its Cancer Transitions of Care.[1][2][3] At pre-seed stage with under $5M raised from investors including F-Prime Capital (2024 investment), Flare Capital, Koa Labs, Techstars, and Oncology Ventures, it launched its first clinic in Pennsylvania and partners with Tennessee Oncology, showing early traction with patient care underway.[1][2][4]
OncoveryCare emerged from co-founder Hil Moss's personal experience as a young breast cancer survivor, who identified gaps in post-treatment care, paired with Dr. Justin Grischkan's clinical expertise as a University of Pennsylvania clinician.[2][3] After interviewing 600 survivors in 2022, they founded the company to create a holistic virtual solution blending clinician-led care with survivor insights, graduating from Techstars 2022 and rapidly launching their first patient-facing clinic in Pennsylvania within months.[2] The team includes key operators like Natasha Rabinowitz Steele (MD, MPH, Clinical Content Peer Support) and Alicia Tan (Director of Operations), with a mission-driven focus on making survivorship a "gift, not a burden" amid rising survivor populations—from millions in 2008 to projected growth by 2032.[2][3][4]
OncoveryCare rides the cancer survivorship wave, fueled by medical advances doubling U.S. survivor numbers (projected surge to 2032), shifting healthcare from cure-focused to long-term management amid ignored post-treatment challenges like chronic issues and mental health.[1][3][4] Timing aligns with healthtech's virtual care boom post-COVID, value-based models favoring preventive survivorship, and AI potential for personalization, positioning it as a leader in the underserved $XXB survivorship market.[2] It influences the ecosystem by pioneering holistic models, partnering with oncology practices like Tennessee Oncology, and attracting top VCs, potentially standardizing survivor care and reducing system burdens.[1][2][4]
OncoveryCare is poised for rapid scaling, expanding virtual clinics state-by-state, deepening AI-driven personalization, and securing larger health system contracts to capture the booming survivor population.[2][3] Trends like aging demographics, precision oncology, and telehealth reimbursement will accelerate growth, evolving its influence from niche innovator to ecosystem shaper in survivorship care. As the first virtual clinic blending survivor insight with clinician expertise, it exemplifies healthtech's human-centered pivot—transforming survival from burden to empowered thriving.[1][4]
OncoveryCare has raised $5.0M in total across 1 funding round.
OncoveryCare's investors include .406 Ventures.
OncoveryCare has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Seed in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2024 | $5.0M Seed | .406 Ventures |